We are live on
!
Find out more
TCP
Tourbillon Capital Partners Portfolio holdings
AUM
$6.26M
1-Year Est. Return
42.29%
This Fund
S&P 500
This Quarter
Est. Return
+1.32%
1 Year Est. Return
-42.29%
3 Year Est. Return
-18.38%
5 Year Est. Return
+32.21%
10 Year Est. Return
–
AUM
$5.2B
AUM Growth
+$1.31B
(+34%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
24.09%
Top 10 Holdings %
Top 10 Hldgs %
48.23%
Holding
88
New
32
Increased
22
Reduced
14
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Spectrum Brands
SPB
|
+$287M |
| 2 |
Corpay
CPAY
|
+$160M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$88M |
| 4 |
Cognizant
CTSH
|
+$67.5M |
| 5 |
WFM
Whole Foods Market Inc
WFM
|
+$60.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CIT
CIT Group Inc.
CIT
|
+$185M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$145M |
| 3 |
Leidos
LDOS
|
+$67.7M |
| 4 |
Huntington Bancshares
HBAN
|
+$53.9M |
| 5 |
Netflix
NFLX
|
+$51.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 13.81% |
| 2 | Consumer Staples | 12.47% |
| 3 | Healthcare | 11.19% |
| 4 | Technology | 9.38% |
| 5 | Consumer Discretionary | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Jazz Pharmaceuticals
JAZZ
$15.9B
| – | – |
-192,407
| Closed | -$27.9M |
|
77
CALL
Kinder Morgan
KMI
$71.5B
| – | – |
-1,000,000
| Closed | -$21.7M |
|
78
PUT
Eli Lilly
LLY
$1.02T
| – | – |
-500,000
| Closed | -$42.1M |
|
79
Neurocrine Biosciences
NBIX
$16.7B
| – | – |
-248,603
| Closed | -$10.8M |
|
|
80
Netflix
NFLX
$299B
| – | – |
-3,513,590
| Closed | -$51.9M |
|
81
CALL
SITE Centers
SITC
$223M
| – | – |
-376,952
| Closed | -$6.09M |
|
|
82
SITE Centers
SITC
$223M
| – | – |
-582,075
| Closed | -$9.4M |
|
83
PUT
TransDigm Group
TDG
$70.6B
| – | – |
-298,400
| Closed | -$65.7M |
|
84
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$22.9B
| – | – |
-2,000,000
| Closed | -$51.3M |
|
|
BWLD
85
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| – | – |
-276,770
| Closed | -$42.3M |
|
|
CIT
86
CALL
DELISTED
CIT Group Inc.
CIT
| – | – |
-1,550,000
| Closed | -$66.5M |
|
|
CIT
87
DELISTED
CIT Group Inc.
CIT
| – | – |
-4,310,208
| Closed | -$185M |
|
|
FGL
88
DELISTED
Fidelity & Guaranty Life
FGL
| – | – |
-1,277,973
| Closed | -$35.5M |
|
Similar funds
BC
LBG
TGA
ACM
MGFS
LA
CT
NMM
Tourbillon Capital Partners's Q2 2017 Portfolio in Review
As of Q2 2017, Tourbillon Capital Partners held 88 positions worth $5.2B, up 34% from $3.88B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Tourbillon Capital Partners deployed $1.25B of net new capital in Q2 2017, opening 32 new positions and adding to 22 existing holdings. Its largest new stake was Spectrum Brands: 2,143,216 shares worth $268M.
By sector, the portfolio is most concentrated in Communication Services at 14% of assets, down from 23% a quarter earlier, followed by Consumer Staples and Healthcare.
On the sell side, the largest reduction was Leidos, an estimated $67.7M trimmed.
- Tourbillon Capital Partners's largest Q2 2017 buy was Spectrum Brands: 2,143,216 shares worth $268M.
- Tourbillon Capital Partners added most to Alexion Pharmaceuticals in Q2 2017, an estimated $88M increase.
- Tourbillon Capital Partners's biggest Q2 2017 reduction was Leidos, cutting an estimated $67.7M.
- Tourbillon Capital Partners fully exited CIT Group Inc. in Q2 2017, selling an estimated $185M.
- Tourbillon Capital Partners's ten largest holdings make up 48% of its $5.2B portfolio in Q2 2017.
- Tourbillon Capital Partners opened 32 new positions and closed 19 in Q2 2017.
- Tourbillon Capital Partners's portfolio value rose 34% quarter-over-quarter to $5.2B.
Based on Tourbillon Capital Partners's 13F filing for Q2 2017, filed 14 Aug 2017.